Back to Search Start Over

Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis.

Authors :
Stassen, Jan
See Hooi Ewe
Butcher, Steele C.
Amanullah, Mohammed R.
Mertens, Bart J.
Hirasawa, Kensuke
Singh, Gurpreet K.
Sin, Kenny Y.
Zee Pin Ding
Pio, Stephan M.
Ching-Hui Sia
Chew, Nicholas
Kong, William
Kian Keong Poh
Cohen, David
Généreux, Philippe
Leon, Martin B.
Marsan, Nina Ajmone
Delgado, Victoria
Bax, Jeroen J.
Source :
Heart; Sep2022, Vol. 10 Issue 17, p1401-1407, 7p
Publication Year :
2022

Abstract

<bold>Objective: </bold>To investigate the prognostic impact of left ventricular (LV) diastolic dysfunction in patients with moderate aortic stenosis (AS) and preserved LV systolic function.<bold>Methods: </bold>Patients with a first diagnosis of moderate AS (aortic valve area >1.0 and ≤1.5 cm2) and preserved LV systolic function (LV ejection fraction ≥50%) were identified. LV diastolic function was evaluated using echocardiographic criteria according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines. Clinical outcomes were defined as all-cause mortality and a composite of all-cause mortality and aortic valve replacement (AVR).<bold>Results: </bold>Of 1247 patients (age 74±10 years, 47% men), 535 (43%) had LV diastolic dysfunction at baseline. Patients with LV diastolic dysfunction showed significantly higher mortality rates at 1-year, 3-year and 5-year follow-up (13%, 30% and 41%, respectively) when compared with patients with normal LV diastolic function (6%, 17% and 29%, respectively) (p<0.001). On multivariable analysis, LV diastolic dysfunction was independently associated with all-cause mortality (HR 1.368; 95% CI 1.085 to 1.725; p=0.008) and the composite endpoint of all-cause mortality and AVR (HR 1.241; 95% CI 1.035 to 1.488; p=0.020).<bold>Conclusions: </bold>LV diastolic dysfunction is independently associated with all-cause mortality and the composite endpoint of all-cause mortality and AVR in patients with moderate AS and preserved LV systolic function. Assessment of LV diastolic function therefore contributes significantly to the risk stratification of patients with moderate AS. Future clinical trials are needed to investigate whether patients with moderate AS and LV diastolic dysfunction may benefit from earlier valve intervention. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13556037
Volume :
10
Issue :
17
Database :
Complementary Index
Journal :
Heart
Publication Type :
Academic Journal
Accession number :
158800997
Full Text :
https://doi.org/10.1136/heartjnl-2022-320886